Home / Hydromorphone / Germany
DE ATC N02AA03 · updated 2 Nov 2026
Hydromorphone shortage in Germany
Is there a Hydromorphone shortage in Germany?
Yes. As of 2 Nov 2026, 7 Hydromorphone products are reported short in Germany, the first since 2 Sep 2024. The company estimate for the return is 21 Dec 2026 (latest 31 Mar 2027). Main reason: increased demand.
Also short in United States, Canada, Switzerland, Sweden. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Hydromorphon PAINBREAK 16 mg Retardtabletten | PB Pharma GmbH | 2 Sep 2024 | 31 Mar 2027 | Increased demand Erhöhte Nachfrage |
| DE | Hydromorphon PAINBREAK 16 mg Retardtabletten | PB Pharma GmbH | 2 Sep 2024 | 31 Mar 2027 | Increased demand Erhöhte Nachfrage |
| DE | Hydromorphon PAINBREAK 24 mg Retardtabletten | PB Pharma GmbH | 2 Sep 2024 | 31 Mar 2027 | Increased demand Erhöhte Nachfrage |
| DE | Hydromorphon PAINBREAK 24 mg Retardtabletten | PB Pharma GmbH | 2 Sep 2024 | 31 Mar 2027 | Increased demand Erhöhte Nachfrage |
| DE | Hydromorphon PAINBREAK 4 mg Retardtabletten | PB Pharma GmbH | 2 Sep 2024 | 31 Mar 2027 | Increased demand Erhöhte Nachfrage |
| DE | Hydromorphon PAINBREAK 8 mg Retardtabletten | PB Pharma GmbH | 2 Sep 2024 | 31 Mar 2027 | Increased demand Erhöhte Nachfrage |
| DE | Hydromorphon HEXAL 10 mg/ml Injektions-/Infusionslösung | H e x a l Aktiengesellschaft | 6 Oct 2026 | 21 Dec 2026 | Other Sonstige |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.